Addressing Resistance to Targeted Therapies in Metastatic Colorectal Cancer
Investigators discuss the use of targeted therapies to treat metastatic colorectal cancer.
The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform
Patients with colorectal cancer could benefit from the COLMATE platform as it allows for opportunities in clinical trial enrollment.